We observe decreased liver inflammation when patients use these treatments 3 , and studies demonstrate a 12% reduction in dementia risk 1
Early data from Versanis bimagrumab (anti-activin II) shows that patients maintain weigh and fat loss for 12 weeks after dose cessation
Ongoing Care Regular follow-ups with progress documentation, clinical assessments, treatment optimization, and protocol adjustments to maximize your regenerative results
To rule out the possibility that the reduced subjective feelings of intoxication in the GLP-1RA group were due to nausea, we assessed nausea levels using a VAS (How nauseous do you feel at this time?) right after each drink during the alcohol administration session
In our clinic, we combine Red Light Therapy with chiropractic adjustments, neuropathy-specific nutrition, and movement therapy to create a comprehensive healing plan